Jackson Creek Investment Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.65M | Buy |
14,476
+2,051
| +17% | +$233K | 0.44% | 109 |
|
|
2025
Q1 | $1.31M | Sell |
12,425
-4,522
| -27% | -$475K | 0.42% | 129 |
|
|
2024
Q4 | $1.82M | Sell |
16,947
-529
| -3% | -$56.7K | 0.55% | 31 |
|
|
2024
Q3 | $1.75M | Buy |
17,476
+3,876
| +29% | +$388K | 0.52% | 45 |
|
|
2024
Q2 | $1.15M | Sell |
13,600
-24
| -0.2% | -$2.02K | 0.42% | 81 |
|
|
2024
Q1 | $996K | Sell |
13,624
-29
| -0.2% | -$2.12K | 0.36% | 158 |
|
|
2023
Q4 | $975K | Sell |
13,653
-4
| -0% | -$286 | 0.37% | 136 |
|
|
2023
Q3 | $818K | Sell |
13,657
-10
| -0.1% | -$599 | 0.35% | 155 |
|
|
2023
Q2 | $985K | Buy |
13,667
+941
| +7% | +$67.8K | 0.39% | 92 |
|
|
2023
Q1 | $936K | Buy |
+12,726
| New | +$936K | 0.39% | 84 |
|
|
2022
Q4 | – | Sell |
-15,429
| Closed | -$829K | – | 340 |
|
|
2022
Q3 | $829K | Buy |
+15,429
| New | +$829K | 0.39% | 116 |
|
|
2020
Q4 | – | Sell |
-11,671
| Closed | -$694K | – | 332 |
|
|
2020
Q3 | $694K | Buy |
+11,671
| New | +$694K | 0.31% | 175 |
|